1
Sudhof T. The synaptic vesicle cycle: a cascade of protein-protein interactions. Nature (London) Published Online First: 6AD.http://wt3cf4et2l.search.serialssolutions.com/?ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info:sid/summon.serialssolutions.com&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The+synaptic+vesicle+cycle%3A+a+cascade+of+protein-protein+interactions&rft.jtitle=Nature&rft.au=Sudhof%2C+Thomas+C&rft.date=1995-06-22&rft.pub=Nature+Publishing+Group&rft.issn=0028-0836&rft.eissn=1476-4687&rft.volume=375&rft.issue=6533&rft.spage=645&rft.externalDBID=BSHEE&rft.externalDocID=17277217&paramdict=en-US
2
The synaptic vesicle cycle: a cascade of protein-protein interactions. http://www.nature.com/nature/journal/v375/n6533/pdf/375645a0.pdf
3
Chen K, Neu A, Howard AL, et al. Prevention of Plasticity of Endocannabinoid Signaling Inhibits Persistent Limbic Hyperexcitability Caused by Developmental Seizures. Journal of Neuroscience 2007;27:46–58. doi:10.1523/JNEUROSCI.3966-06.2007
4
Krisztina, Massa F, Egertová M, et al. The Endocannabinoid System Controls Key Epileptogenic Circuits in the Hippocampus. http://www.sciencedirect.com.ezproxy.library.qmul.ac.uk/science/article/pii/S0896627306005460
5
Nyilas R, Dudok B, Urbán GM. Enzymatic Machinery for Endocannabinoid Biosynthesis Associated with Calcium Stores in Glutamatergic Axon Terminals. http://www.jneurosci.org.ezproxy.library.qmul.ac.uk/content/28/5/1058
6
Solinas M, Goldberg SR, Piomelli D. The endocannabinoid system in brain reward processes. British Journal of Pharmacology 2009;154:369–83. doi:10.1038/bjp.2008.130
7
The endocannabinoid system in brain reward processes. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2442437/pdf/bjp2008130a.pdf
8
Arendt T. Alzheimer’s disease as a disorder of mechanisms underlying structural brain self-organization. http://www.sciencedirect.com.ezproxy.library.qmul.ac.uk/science/article/pii/S0306452200005169
9
Arendt T. Alzheimer’s disease as a disorder of mechanisms underlying structural brain self-organization. http://www.sciencedirect.com.ezproxy.library.qmul.ac.uk/science/article/pii/S0306452200005169
10
Dominguez ID, Strooper BD. Novel therapeutic strategies provide the real test for the amyloid hypothesis of Alzheimer’s disease. http://www.sciencedirect.com.ezproxy.library.qmul.ac.uk/science/article/pii/S0165614702020382
11
Bezard E, Brotchie JM, Gross CE. Pathophysiology of levodopa-induced dyskinesia: Potential for new therapies : Article : Nature Reviews Neuroscience. http://www.nature.com.ezproxy.library.qmul.ac.uk/nrn/journal/v2/n8/full/nrn0801_577a.html
12
McMurray CT. Huntington’s disease: new hope for therapeutics. http://www.sciencedirect.com.ezproxy.library.qmul.ac.uk/science/article/pii/S0166223601000066
13
De Keyser J, Sulter G, Luiten PG. Clinical trials with neuroprotective drugs in acute ischaemic stroke: are we doing the right thing? http://www.sciencedirect.com.ezproxy.library.qmul.ac.uk/science/article/pii/S0166223699014630
14
Zhu HL, Luo WQ, Wang H. Iptakalim protects against hypoxic brain injury through multiple pathways associated with ATP-sensitive potassium channels. http://www.sciencedirect.com.ezproxy.library.qmul.ac.uk/science/article/pii/S0306452208014024
15
Fredrik Jarskog L, Miyamoto S, Lieberman JA. Schizophrenia: New Pathological Insights and Therapies - Annual Review of Medicine, 58(1):49. http://www.annualreviews.org.ezproxy.library.qmul.ac.uk/doi/abs/10.1146/annurev.med.58.060904.084114
16
Iritani S. Neuropathology of schizophrenia: A mini review. Neuropathology 2007;27:604–8. doi:10.1111/j.1440-1789.2007.00798.x
17
LARUELLE M, KEGELES LS, ABI-DARGHAM A. Glutamate, Dopamine, and Schizophrenia. Annals of the New York Academy of Sciences 2003;1003:138–58. doi:10.1196/annals.1300.063
18
Torrey EF, Barci BM, Webster MJ, et al. Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains. Biological Psychiatry 2005;57:252–60. doi:10.1016/j.biopsych.2004.10.019
19
Löscher W. Current status and future directions in the pharmacotherapy of epilepsy. http://www.sciencedirect.com.ezproxy.library.qmul.ac.uk/science/article/pii/S016561470001974X
20
Mulley JC, Scheffer IE, Petrou S, et al. Channelopathies as a genetic cause of epilepsy. http://ovidsp.tx.ovid.com.ezproxy.library.qmul.ac.uk/sp-3.16.0a/ovidweb.cgi?&S=OLHFFPBBICDDHECMNCKKKBIBBLDIAA00&Link+Set=jb.search.31%7c1%7csl_10
21
Mulley JC, Scheffer IE, Petrou S, et al. Channelopathies as a genetic cause of epilepsy. http://ovidsp.tx.ovid.com.ezproxy.library.qmul.ac.uk/sp-3.16.0a/ovidweb.cgi?WebLinkFrameset=1&S=OLHFFPBBICDDHECMNCKKKBIBBLDIAA00&returnUrl=ovidweb.cgi%3f%26Full%2bText%3dL%257cjb.search.31.32%257c0%257c00019052-200304000-00009%26S%3dOLHFFPBBICDDHECMNCKKKBIBBLDIAA00&directlink=http%3a%2f%2fgraphics.tx.ovid.com%2fovftpdfs%2fFPDDNCIBKBCMIC00%2ffs004%2fovft%2flive%2fgv006%2f00019052%2f00019052-200304000-00009.pdf&filename=Channelopathies+as+a+genetic+cause+of+epilepsy.&pdf_key=FPDDNCIBKBCMIC00&pdf_index=/fs004/ovft/live/gv006/00019052/00019052-200304000-00009&D=ovft
22
Maalouf M, Rho JM, Mattson MP. The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies. http://www.sciencedirect.com.ezproxy.library.qmul.ac.uk/science/article/pii/S0165017308001045
23
Schmitz B, Montouris G, Schäuble B, et al. Assessing the unmet treatment need in partial-onset epilepsy: Looking beyond seizure control. Epilepsia 2010;51:2231–40. doi:10.1111/j.1528-1167.2010.02759.x
24
Nestler EJ. Is there a common molecular pathway for addiction? : Article : Nature Neuroscience. http://www.nature.com.ezproxy.library.qmul.ac.uk/neuro/journal/v8/n11/full/nn1578.html
25
Dackis C, O’Brien C. Neurobiology of addiction: treatment and public policy ramifications : Article : Nature Neuroscience. http://www.nature.com.ezproxy.library.qmul.ac.uk/neuro/journal/v8/n11/full/nn1105-1431.html
26
Volkow ND, Fowler JS, Wang G-J. The addicted human brain viewed in the light of imaging studies: brain circuits and treatment strategies. http://www.sciencedirect.com.ezproxy.library.qmul.ac.uk/science/article/pii/S0028390804002163
